This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feldman, R. L. Articles by Pepine, C. J. Search for Related Content PubMed PubMed Citation Articles by Feldman, R. L. Articles by Pepine, C. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PROPRANOLOL HYDROCHLORIDE

Circulation, Vol 73, 727-733, Copyright © 1986 by American Heart Association

ARTICLES

Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion

RL Feldman, RG MacDonald, JA Hill, MC Limacher, CR Conti and CJ Pepine

In 16 patients undergoing angioplasty of the left anterior descending coronary artery, the clinical, electrocardiographic, and hemodynamic effects of short-term intravenous nonselective beta-adrenergic blockade with propranolol (0.1 mg/kg) were assessed during temporary occlusion of the artery. Myocardial ischemia during coronary occlusion was prevented, delayed in onset, or diminished in magnitude by propranolol in 10 of the 16 patients. Propranolol decreased values for indexes of myocardial oxygen demand, such as heart rate and blood pressure and their product, in all patients. Surprisingly, in patients who derived clinical benefit, propranolol did not change indexes of myocardial oxygen supply to the left ventricular region perfused by the occluded artery. For example, great cardiac vein flow (40 +/- 15 to 41 +/- 17 ml/min, p = NS) and coronary collateral resistance (2.1 +/- 1.0 to 2.1 +/- 1.1 mm Hg/ml/min, p = NS) were unchanged. In contrast, a worsening of supply occurred in patients who were not benefited: great cardiac vein flow (50 +/- 10 to 39 +/- 6 ml/min, p less than .05) decreased and coronary collateral resistance (1.6 +/- 0.5 to 2.0 +/- 0.6 mm Hg/ml/min, p less than .05) increased. Information obtained from this study demonstrates the value of this new experimental preparation in helping assess potential clinical effectiveness of drug interventions during the initial phase of acute coronary occlusion and providing insight into the mechanisms of drug effect.

This article has been cited by other articles:

				F. W. Wang, A. Osman, J. Otero, G. A. Stouffer, S. Waxman, A. Afzal, A. Anzuini, and B. F. Uretsky Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary {beta}-Blocker Circulation, June 17, 2003; 107(23): 2914 - 2919. [Abstract] [Full Text] [PDF]

				M. Billinger, M. Fleisch, F. R. Eberli, B. Meier, and C. Seiler Collateral and collateral-adjacent hyperemic vascular resistance changes and the ipsilateral coronary flow reserve: Documentation of a mechanism causing coronary steal in patients with coronary artery disease Cardiovasc Res, February 16, 2001; 49(3): 600 - 608. [Abstract] [Full Text] [PDF]

				J. J. Piek, R. A. M. van Liebergen, K. T. Koch, R. J. de Winter, R. J. G. Peters, and G. K. David Pharmacological Modulation of the Human Collateral Vascular Resistance in Acute and Chronic Coronary Occlusion Assessed by Intracoronary Blood Flow Velocity Analysis in an Angioplasty Model Circulation, July 1, 1997; 96(1): 106 - 115. [Abstract] [Full Text]

				Y. Birnbaum, K. Przyklenk, and R. A. Kloner Time Frame of Ischemic Preconditioning: Is It Clinically Relevant? Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 1996; 1(4): 339 - 346. [PDF]